Press Releases
GT Biopharma Appoints Manu Ohri as Chief Financial Officer
GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference
GT Biopharma Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GT Biopharma Demonstrates Novel B7-H3 Targeting Dual Camelid Nanobody BiKE and GTB-5550 Induce NK Cell Activation Against Broad Spectrum of Tumors at ESMO IO Congress 2021
GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targeting Broad Spectrum Solid and Hematologic Malignancies Accepted for Presentation at ESMO IO Congress 2021
GT BioPharma to Host a Management Update Conference Call
GT BioPharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update
GT Biopharma Announces Executive Leadership Transition to Implement Next Phase of Strategic Journey
GT BioPharma's Next Generation Camelid TriKE® Nanobody Platform Highlighted at ESMO Congress 2021
